A Comparative Study Of Shatapushpa powder and Patadee powder in the management of Granthibhoota Artava dushti W.S.R. PCOS
试验速览
- 阶段
- 2/3 期
- 状态
- Not Applicable
- 发起方
- 入组人数
- 86
- 试验地点
- 1
- 主要终点
- Improvement of the clinical outcomes of PCOS with improving menstrual regularity.
研究概览
简要总结
Pathadi Yoga said in the context of Granthiboota arthavadushti , is an effective drug to be used in PCOS. The Deepana and Pachana properties of Trikatu, Kutaja, and Patha are well-documented in Ayurveda for their role in stimulating the digestive fire (Agni) and promoting effective digestion and metabolism*,* Properties of Shatakuppa make it highly beneficial in balancing Vata and Kapha doshas. Shatpushpa (Anethum sowa) exhibits multiple pharmacological actions that align with its traditional Ayurveda uses in managing metabolic, digestive, and reproductive health issues. According to Kashyapa Samhita Artava (Ovam) has having Agney (Hot) property Shathapushpa is with Katu Rasa and Ushna Virya can be used for the purpose formation of Stree Beeja (Ovulation). And Shatapushpa, promoter of digestive fire (Agni Vardhani), has properties that initiate menstruation(Ritu Pravartani).
The bioactive compounds associated with Shatpushpa, improve digestive and metabolic processes and support reproductive health by promoting tissue nourishment and regulating menstrual flow.
By comparing Shatapushpa Powder with Patadee Powder, the study seeks not only to confirm Shatapushpa’s efficacy in a controlled clinical setting but also to investigate whether Patadee Powder offers comparable or enhanced therapeutic benefits. Given that Shatapushpa is already standard in Ayurveda practice for Granthibhoota artavadushti, this study could also help standardize the use of these powders by providing clinical evidence of their efficacy, safety, and potential benefits over one another.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 35.00 Year(s)（—）
- 性别
- Female
入选标准
- •Married/ Unmarried Women aged 18-35 years II.
- •Diagnosed with PCOS based on Rotterdam criteria (2 out of 3 symptoms if present).
排除标准
- •Patients below 18 years and above 35 years.
- •Intake of any testosterone level modifying drugs in the 3 months prior to study inclusion.
- •Female participants who are ovariectomized, hysterectomized or post-menopausal IV.
- •Pregnant or lactating women V.
- •Potentially severe immunosuppression or intake of other immunosuppressive drugs VI.
- •Other clinically significant concomitant disease states (e.g., renal failure, active carcinoma), and women with other endocrine disorders.
结局指标
主要结局
Improvement of the clinical outcomes of PCOS with improving menstrual regularity.
时间窗: 12 WEEKS
次要结局
- Improvement in free testosterone level.(Improvement in Ovarian Volume.)
研究者
K H P Ranathunga
Bandaranayake Memorial Ayurveda Research Institute